Related Experiment Video

Updated: Jun 20, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

The influence of microglia on the pathogenesis of Parkinson's disease

Caitríona M Long-Smith1, Aideen M Sullivan, Yvonne M Nolan

  • 1Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.

Progress in Neurobiology
|August 19, 2009
PubMed

Insights

Inflammation, particularly microglial activation, plays a key role in Parkinson's disease (PD) pathogenesis. Targeting microglia may offer novel therapeutic strategies for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuropathology

Background:

  • Parkinson's disease (PD) involves the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc).
  • Growing evidence links inflammation to PD neuropathology, including microglial activation and elevated pro-inflammatory cytokines (TNF-α, IL-1β) in PD patients' SNpc.
  • Factors like influenza infection, bacterial vaginosis, and inflammatory mediators in animal models suggest inflammation's contribution to PD.

Purpose of the Study:

  • To review the role of inflammation in the pathogenesis of Parkinson's disease.
  • To highlight the influence of microglia in PD development.
  • To discuss potential microglial-targeting therapeutic interventions for PD.

Main Methods:

  • Literature review focusing on the role of inflammation and microglia in Parkinson's disease.
  • Analysis of evidence linking inflammatory processes and PD.
  • Examination of potential therapeutic strategies targeting microglial activation.

Main Results:

  • Excessive microglial activation and increased pro-inflammatory cytokines are observed in the SNpc of PD patients.
  • Inflammatory mediators are present in PD animal models, and anti-inflammatory drugs show potential in reducing PD susceptibility.
  • Microglial activation inhibitors are emerging as potential therapeutic agents for PD.

Conclusions:

  • Inflammation, especially microglial activation, is significantly implicated in the neuropathology of Parkinson's disease.
  • Microglia play a crucial role in the pathogenesis of PD.
  • Targeting microglial activation presents a promising therapeutic avenue for Parkinson's disease treatment.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...